Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Irene López-RojoSusana Olmedillas-LópezPedro Villarejo CamposVíctor Domínguez PrietoJavier Barambio BuendíaDelia Cortés GuiralMariano García-ArranzDamián García-OlmoPublished in: Therapeutic advances in medical oncology (2020)
Treatment with CC-HIPEC does not always neutralize ctDNA in peritoneal fluid, and its persistence after treatment may predict adverse outcome. Despite being a proof of concept, an adequate correlation between liquid biopsy in plasma and peritoneal fluid with both systemic and peritoneal relapse has been observed.